Chemoimmunotherapy for esophageal squamous cell carcinoma—Summary and discussion of recent clinical trials
Abstract As a kind of carcinoma with increasing morbidity, poor prognosis, and high mortality, esophageal squamous cell carcinoma (ESCC) is challenging for clinical management. Chemotherapy has been the standard treatment for ESCC over decades, while its clinical outcomes remain unsatisfying. And th...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-06-01
|
| Series: | MedComm – Future Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/mef2.56 |